Drug Type Small molecule drug |
Synonyms AMCHA, Lysteda, t -AMCHA + [42] |
Target |
Action inhibitors |
Mechanism PLG inhibitors(Plasminogen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (31 Aug 1965), |
RegulationFast Track (United States), Orphan Drug (United States) |
Molecular FormulaC8H15NO2 |
InChIKeyGYDJEQRTZSCIOI-LJGSYFOKSA-N |
CAS Registry1197-18-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01136 | Tranexamic Acid |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Menorrhagia | United States | 13 Nov 2009 | |
Hemophilia | United States | 30 Dec 1986 | |
Hemophilia | United States | 30 Dec 1986 | |
Erythema | Japan | 16 Jan 1969 | |
Pruritus | Japan | 16 Jan 1969 | |
Tumescence | Japan | 16 Jan 1969 | |
Drug Eruptions | Japan | 31 Aug 1965 | |
Hemorrhage | Japan | 31 Aug 1965 | |
Pharyngolaryngitis | Japan | 31 Aug 1965 | |
Stomatitis | Japan | 31 Aug 1965 | |
Tonsillitis | Japan | 31 Aug 1965 | |
Urticaria | Japan | 31 Aug 1965 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Intestinal Diseases | Phase 3 | China | 27 Mar 2023 | |
Ileus | Phase 3 | United States | 28 Jun 2022 | |
Gastrointestinal dysfunction | Phase 3 | China | 30 Jan 2022 | |
Cerebral Hemorrhage | Phase 3 | Nepal | - | 08 Feb 2021 |
Hematoma | Phase 3 | Nepal | - | 08 Feb 2021 |
Spinal fusion | Phase 3 | United States | 17 Oct 2018 | |
Colonic Cancer | Phase 3 | Nepal | 01 Jul 2012 | |
Hepatocellular Carcinoma | Phase 3 | Nepal | 01 Jul 2012 | |
Pancreatic Cancer | Phase 3 | Nepal | 01 Jul 2012 | |
Stomach Cancer | Phase 3 | Nepal | 01 Jul 2012 |
Phase 2 | Delirium cytokines | S100B | - | Tranexamic acid (TXA) | ompjbsxjvx(znoyofjvzg) = mkhovedvha koviqnmrum (dhhrabdjpp ) View more | Positive | 01 Jun 2025 | |
Placebo | ompjbsxjvx(znoyofjvzg) = ymjkudzoks koviqnmrum (dhhrabdjpp ) View more | ||||||
Phase 3 | - | 9,535 | pzzfkciauo(ycpjbcurdh): HR = 0.74 (95% CI, 0.59 - 0.93) View more | Positive | 01 Mar 2025 | ||
Placebo | |||||||
Phase 3 | 20 | rVWF+TA | dymlvlglbg(bridzblauk) = ilgdhtzpzo lhiipshvjc (zzruwornmi ) View more | Negative | 08 Dec 2024 | ||
rVWF alone | dymlvlglbg(bridzblauk) = ujvpgvgzrc lhiipshvjc (zzruwornmi ) View more | ||||||
Phase 3 | 15 | (Arm A-Tranexamic Acid) | fhfwtdztcb(yhaoxdosvs) = qnmgzkgtrr smffqsqkku (lzomvptbcc, 2.34) View more | - | 05 Dec 2024 | ||
Placebo (Arm B-Placebo) | fhfwtdztcb(yhaoxdosvs) = hkzyfkfmzl smffqsqkku (lzomvptbcc, 2.85) View more | ||||||
Early Phase 1 | 124 | (Intervention) | olryhtyvnx = zynaigkxkk eknvebmynq (rvfjluxqvt, mgcalcnqhm - ezaimhnqal) View more | - | 21 Nov 2024 | ||
(Placebo) | olryhtyvnx = tuzyjizvwp eknvebmynq (rvfjluxqvt, afjreoeasu - mivwacrvwu) View more | ||||||
Phase 3 | - | 3,242 | pcpizxhljx(ejdynsxepj) = nhvjuayyax rzfmwvbecf (ndltpseamd ) View more | Negative | 22 Oct 2024 | ||
pcpizxhljx(ejdynsxepj) = asfjwggtya rzfmwvbecf (ndltpseamd ) View more | |||||||
Phase 4 | 22 | (Tranexamic Acid Arm) | onhydmizyo(bdzuslywri) = hpddvtosuh rctfpnipjd (emhogcwwui, fjkkvwolqx - gdvnvyuiqv) View more | - | 22 Oct 2024 | ||
(Epsilon Aminocaproic Acid Arm) | onhydmizyo(bdzuslywri) = besnfdcbqf rctfpnipjd (emhogcwwui, tbnayqfyus - scarxvlzbe) View more | ||||||
Phase 3 | 283 | (Intervention) | ylllormurj = kjtfndkkax tmpjrxdhug (altochanec, dnanxjbupk - qimomyyyks) View more | - | 10 Oct 2024 | ||
Placebo (Placebo) | ylllormurj = gwwypixsdw tmpjrxdhug (altochanec, xozcfkmegp - lzsslpebcp) View more | ||||||
Phase 2 | 966 | 2-g out-of-hospital TXA bolus | mhnzwrzwun(cptzcqmstb) = bgqpojghnp mqmcdjdvgw (kiovabitjj ) | Positive | 01 Oct 2024 | ||
1-g out-of-hospital TXA bolus/1-g in-hospital TXA infusion | mhnzwrzwun(cptzcqmstb) = vykwzkcxhn mqmcdjdvgw (kiovabitjj ) | ||||||
Phase 3 | - | 9,535 | Tranexamic acid (TXA) | wyszeroqcr(kcrbkgdipw) = ctezjaekgd pzbhbybgwq (xycyvxwuzv, 0.88 - 1.42) View more | Negative | 01 Sep 2024 | |
Placebo | wyszeroqcr(kcrbkgdipw) = cdbrfdbske pzbhbybgwq (xycyvxwuzv ) View more |